From StructContinue beyond “Fourteen stocks are moving together across nine sectors”Back to the brief ↗Feed / ADMA

ADMA Biologics, Inc.

ADMA

Healthcare · 9.76 -1.2% today

You’ve read what changed. Here’s whether the market is confirming it.

Partial group confirmationMarket checked 10 Aug, 15:55 GMT-4

Jodie situation report

ADMA Biologics, Inc.'s move is spreading beyond its market group.

ADMA accounts for 8.3% of the group's measured movement across 5.7 effective names. raw member direction is mixed; 0 of 12 session-normalized paths align to the mixed. Capital-flow agreement is 8%, so confirmation is not yet clean. No verified headline preceded the measured group move.

MOVE ANATOMY

Is this move genuinely shared?

Session-normalized 5m paths
Role in the moveIndependent mover#5 of 12 by movement share
Group movement share8.3%Absolute path energy—not portfolio weight
Relative path-1.22%mixed
Effective breadth5.7 / 12balanced
Relative alignment0/12mixed path · 0 counter-moving
Capital-flow agreement8%not yet clean
SEQUENCE READ

No material onset for ADMA could be timestamped inside the aligned 5-minute window.

No material onset for this name could be timestamped inside the aligned 5-minute window.Biotechnology Therapeutics
What changed
  • Revenue increased 2.0% versus the comparable filing period.
EVIDENCE COVERAGE

10 of 12 members in Biotechnology Therapeutics are active. 1 of 8 disclosed connections are confirming.

What would change this read
  • At least 8 of 12 members remain active in the next snapshot.
  • Capital-flow agreement rises above 55%.
  • TAK remains aligned with the group in the next market snapshot.

Invalidation: The live read weakens if participation falls to 4 of 12 members or fewer.

Watch this read

Who this business touches

The relationships behind ADMA

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

JPMJP Morgan Chase & Co.lenderMay 6, 2026 ▾

“JPM Credit Agreement On August 5, 2025 (the “JPM Closing Date”), we entered into a Credit Agreement (the “JPM Credit Agreement”) with the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent.”

GRFSFiling-linked namecompetitorFeb 25, 2026 ▾

“In December 2018, our former contract manufacturer assigned its rights and obligations under the 2011 Plasma Purchase Agreement to Grifols Worldwide Operations Limited (“Grifols”) as its successor-in-interest, effective January 2019.”

Depended on by

HTGCHercules Capital, Inc.investeeOct 30, 2025 ▾

“Our gains were offset by gross realized losses of $3.3 million and $15.0 million, respectively, for the three and nine month periods, from the write-off of equity and warrant investments in Proterra, Inc., The Faction Group LLC, Udacity, Inc., Humanigen, Inc.…”

Filing peers

ASMBRLYB

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 5 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

ADMA is currently a Participant in the organic co-movement group Biotechnology Therapeutics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for ADMA; it is not active in the latest market snapshot.